Table 6.

Relative size of incentive payments to revenue

Scheme, study	Country	Payment/Revenue (%)
Spontaneous breathing trials (SBTs), [8]	US	7.5
CAPI-ROSP, [9–11]	France	4–7
Rwanda P4P, [12]	Rwanda	22
P4P for Maternal care, [13–15]	Tanzania	10–25
P4P for Antibiotics, [16]	Sweden	0.05–1.2
Quality and Outcomes Framework, [17]	UK	25
Afghanistan P4P, [18]	Afghanistan	6–28